State Street Corp Puma Biotechnology, Inc. Transaction History

State Street Corp

$2.8 Trillion
Q3 2025

A detailed history of State Street Corp transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, State Street Corp holds 748,658 shares of PBYI stock, worth $3.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

748,658

Previous 734,606 1.91%

Holding current value

$3.71 Million

Previous $2.52 Million 52.44%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$3.07 - $5.73 $43,139 - $80,517	14,052 Added 1.91%	748,658 $3.84 Million
Q2 2025 Aug 14, 2025	BUY	$2.74 - $3.72 $232,390 - $315,508	84,814 Added 13.05%	734,606 $2.52 Million
Q1 2025 May 15, 2025	BUY	$2.76 - $3.88 $109,985 - $154,618	39,850 Added 6.53%	649,792 $1.92 Million
Q4 2024 Feb 14, 2025	BUY	$2.42 - $3.39 $20,328 - $28,476	8,400 Added 1.4%	609,942 $1.86 Million
Q3 2024 Nov 14, 2024	BUY	$2.25 - $4.03 $196,884 - $352,641	87,504 Added 17.02%	601,542 $1.53 Million

Q2 2024 Aug 14, 2024	BUY	$2.92 - $5.83 $997,343 - $1.99 Million	341,556 Added 198.02%	514,038 $1.68 Million
Q1 2024 May 15, 2024	BUY	$4.29 - $7.4 $42,900 - $74,000	10,000 Added 6.15%	172,482 $914,000
Q3 2023 Nov 14, 2023	SELL	$2.63 - $4.09 $10,772 - $16,752	-4,096 Reduced 2.46%	162,482 $427,000
Q2 2023 Aug 14, 2023	SELL	$2.6 - $3.58 $57,254 - $78,835	-22,021 Reduced 11.68%	166,578 $588,000
Q4 2022 Feb 14, 2023	BUY	$2.12 - $5.08 $14,619 - $35,031	6,896 Added 3.8%	188,599 $797,000
Q2 2022 Aug 15, 2022	SELL	$1.64 - $3.3 $750,998 - $1.51 Million	-457,926 Reduced 71.59%	181,703 $518,000
Q1 2022 May 16, 2022	BUY	$2.13 - $3.24 $131,078 - $199,386	61,539 Added 10.65%	639,629 $1.84 Million
Q4 2021 Feb 14, 2022	SELL	$2.85 - $6.58 $169,945 - $392,365	-59,630 Reduced 9.35%	578,090 $1.76 Million
Q3 2021 Nov 15, 2021	SELL	$6.63 - $9.39 $5.91 Million - $8.37 Million	-891,800 Reduced 58.31%	637,720 $4.47 Million
Q2 2021 Aug 16, 2021	SELL	$8.98 - $11.6 $7.13 Million - $9.21 Million	-793,635 Reduced 34.16%	1,529,520 $14 Million
Q1 2021 May 17, 2021	BUY	$9.38 - $13.63 $760,886 - $1.11 Million	81,118 Added 3.62%	2,323,155 $22.6 Million
Q4 2020 Feb 16, 2021	SELL	$7.78 - $12.13 $4.5 Million - $7.02 Million	-578,604 Reduced 20.51%	2,242,037 $23 Million
Q3 2020 Nov 10, 2020	SELL	$9.5 - $11.14 $5.26 Million - $6.16 Million	-553,216 Reduced 16.4%	2,820,641 $28.5 Million
Q2 2020 Aug 14, 2020	SELL	$7.01 - $13.24 $1.16 Million - $2.19 Million	-165,763 Reduced 4.68%	3,373,857 $35.2 Million
Q1 2020 May 11, 2020	BUY	$6.28 - $14.57 $22.2 Million - $51.6 Million	3,539,620 New	3,539,620 $29.9 Million

Others Institutions Holding PBYI

# of Institutions

135

Shares Held

35.2M

Call Options Held

264K

Put Options Held

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $226M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Puma Biotechnology, Inc. Transaction History